1-DEAZA-7,8-dihydropteridines, a new class of mitotic inhibitors with anticancer activity
- 15 August 1981
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 30 (16), 2381-2384
- https://doi.org/10.1016/0006-2952(81)90120-9
Abstract
No abstract availableFunding Information
- National Institutes of Health
This publication has 8 references indexed in Scilit:
- Inhibition of tubulin polymerization by MebendazoleBiochemical and Biophysical Research Communications, 1980
- Inactivation by the mitotic inhibitor NY 3170 of human cells in vitroBritish Journal of Cancer, 1979
- Cell-cycle inhibitory effects of the mitotic inhibitor NY 3170 on human cells in vitroBritish Journal of Cancer, 1979
- Differential binding of methyl benzimidazol-2-yl carbamate to fungal tubulin as a mechanism of resistance to this antimitotic agent in mutant strains of Aspergillus nidulansThe Journal of cell biology, 1977
- Interaction of oncodazole (R 17934), a new anti-tumoral drug, with rat brain tubulinBiochemical and Biophysical Research Communications, 1976
- R17934-NSC238159: A new antitumor drug—II. Effect on mitotic cycle of L1210 leukemia cells in vivo and synergism with cytosine arabinoside (NSC 63878)European Journal of Cancer (1965), 1975
- 5-Fluoropyrimidin-2-one, a new metaphase arresting agentBiochemical Pharmacology, 1972
- Potential folic acid antagonists. III. Deaza analogs of methotrexate. III. 1- and 3-deaza analogs of 2,4-diamino-6-[(N-methylanilino)methyl]pteridineThe Journal of Organic Chemistry, 1968